New Stem Cell Company Launched to Benefit Human and Veterinary Patients

29-Dec-2010 - USA

A new collaboration between a human clinical cell processing facility and tissue bank (General BioTechnology, LLC) and clinical experts in hematology/oncology, oral surgery and veterinary medicine has been launched. RenovoCyte, LLC is a cellular medicine company that is dedicated to the use of multipotent mesenchymal stromal-stem cell (MSC) therapy in the fields of veterinary and human medicine. The goal of RenovoCyte is to work hand-in-hand with veterinarians and medical doctors to establish a gold standard for the use of cell therapy in order to help treat various disease processes.

RenovoCyte originated from General Biotechnology, LLC in Indianapolis who has many years of experience in cell therapy, research, cryopreservation, cell and tissue processing, banking, manufacturing and transport. Utilizing General Biotechnology (GBT) as an in-house laboratory, RenovoCyte is capable of producing products and technology in the field of cellular medicine. GBT and RenovoCyte share the same CEO, President and founder, Erik Woods, PhD., who leads the science behind RenovoCyte as well as the clinical team.

RenovoCyte's services include cell processing, expansion, banking and cell therapy in both human and veterinary patients. Veterinary species include the dog, horse, cat and rabbit.

https://www.bionity.com/en/news/130055/new-stem-cell-company-launched-to-benefit-human-and-veterinary-patients.html